Specify a stock or a cryptocurrency in the search bar to get a summary
India Globalization Capital Inc
IGCIGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland. Address: 10224 Falls Road, Potomac, MD, United States, 20854
Analytics
WallStreet Target Price
3.63 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures IGC
Dividend Analytics IGC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IGC
Stock Valuation IGC
Financials IGC
Results | 2019 | Dynamics |